Pharmasset looked at the drug-drug interactions with Telaprevir in vitro and concluded that antagonistic interaction is unlikely in clinical studies given the duplicity of enzymatic pathways available for delivery of the triphosphate intracellularly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.